Source: Scientific Reports. Unidade: IME
Subjects: BIOINFORMÁTICA, NEOPLASIAS PULMONARES
ABNT
NAKATA, Asuka et al. Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Scientific Reports, v. 5, 2015Tradução . . Disponível em: https://doi.org/10.1038/srep13076. Acesso em: 01 set. 2024.APA
Nakata, A., Yoshida, R., Yamaguchi, R., Yamauchi, M., Tamada, Y., Fujita, A., et al. (2015). Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Scientific Reports, 5. doi:10.1038/srep13076NLM
Nakata A, Yoshida R, Yamaguchi R, Yamauchi M, Tamada Y, Fujita A, Shimamura T, Imoto S, Higuchi T, Nomura M, Kimura T, Nokihara H, Higashiyama M, Kondoh K, Nishihara H, Tojo A, Yano S, Miyano S, Gotoh N. Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs [Internet]. Scientific Reports. 2015 ; 5[citado 2024 set. 01 ] Available from: https://doi.org/10.1038/srep13076Vancouver
Nakata A, Yoshida R, Yamaguchi R, Yamauchi M, Tamada Y, Fujita A, Shimamura T, Imoto S, Higuchi T, Nomura M, Kimura T, Nokihara H, Higashiyama M, Kondoh K, Nishihara H, Tojo A, Yano S, Miyano S, Gotoh N. Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs [Internet]. Scientific Reports. 2015 ; 5[citado 2024 set. 01 ] Available from: https://doi.org/10.1038/srep13076